Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0002032492-24-000001
Filing Date
2024-08-07
Accepted
2024-08-07 16:43:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 4877
3 avsignature2.pdf EX-99.16 PWR OF ATTY 104501
  Complete submission text file 0002032492-24-000001.txt   150133
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Subject) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SCHEDULE 13D | Act: 34 | File No.: 005-87280 | Film No.: 241184520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9300 SOUTH DADELAND BLVD. 4TH FLOOR MIAMI FL 33156
Business Address 9300 SOUTH DADELAND BLVD. 4TH FLOOR MIAMI FL 33156 2122664026
Quintairos, Prieto, Wood & Boyer P.A. (Filed by) CIK: 0002032492 (see all company filings)

EIN.: 593502785 | State of Incorp.: FL
Type: SCHEDULE 13D